Wuhan YZY Biopharma Co., Ltd. (HKG:2496)

Wuhan YZY Biopharma Statistics

Total Valuation

HKG:2496 has a market cap or net worth of HKD 1.40 billion. The enterprise value is 1.39 billion.

Market Cap	1.40B
Enterprise Value	1.39B

Important Dates

The next estimated earnings date is Friday, March 27, 2026.

Earnings Date	Mar 27, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:2496 has 193.85 million shares outstanding. The number of shares has increased by 1.47% in one year.

Current Share Class	111.47M
Shares Outstanding	193.85M
Shares Change (YoY)	+1.47%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	19.52%
Owned by Institutions (%)	8.61%
Float	18.51M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	8.58
PB Ratio	-46.67
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-16.29
EV / Sales	8.51
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-40.86

Financial Position

The company has a current ratio of 0.92

Current Ratio	0.92
Quick Ratio	0.84
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-5.04
Interest Coverage	-16.89

Financial Efficiency

Return on equity (ROE) is -704.81% and return on invested capital (ROIC) is -31.31%.

Return on Equity (ROE)	-704.81%
Return on Assets (ROA)	-18.74%
Return on Invested Capital (ROIC)	-31.31%
Return on Capital Employed (ROCE)	-275.56%
Weighted Average Cost of Capital (WACC)	-1.79%
Revenue Per Employee	1.54M
Profits Per Employee	-806,711
Employee Count	106
Asset Turnover	0.60
Inventory Turnover	11.54

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -0.82% in the last 52 weeks. The beta is -1.19, so HKG:2496's price volatility has been lower than the market average.

Beta (5Y)	-1.19
52-Week Price Change	-0.82%
50-Day Moving Average	7.52
200-Day Moving Average	6.17
Relative Strength Index (RSI)	29.95
Average Volume (20 Days)	6,400

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2496 had revenue of HKD 163.65 million and -85.51 million in losses. Loss per share was -0.44.

Revenue	163.65M
Gross Profit	106.38M
Operating Income	-82.06M
Pretax Income	-85.51M
Net Income	-85.51M
EBITDA	-76.79M
EBIT	-82.06M
Loss Per Share	-0.44

Balance Sheet

The company has 182.10 million in cash and 171.67 million in debt, with a net cash position of 10.43 million or 0.05 per share.

Cash & Cash Equivalents	182.10M
Total Debt	171.67M
Net Cash	10.43M
Net Cash Per Share	0.05
Equity (Book Value)	-30.07M
Book Value Per Share	-0.16
Working Capital	-18.80M

Cash Flow

In the last 12 months, operating cash flow was -33.25 million and capital expenditures -849,230, giving a free cash flow of -34.10 million.

Operating Cash Flow	-33.25M
Capital Expenditures	-849,230
Free Cash Flow	-34.10M
FCF Per Share	-0.18

Margins

Gross margin is 65.01%, with operating and profit margins of -50.14% and -52.25%.

Gross Margin	65.01%
Operating Margin	-50.14%
Pretax Margin	-52.25%
Profit Margin	-52.25%
EBITDA Margin	-46.92%
EBIT Margin	-50.14%
FCF Margin	n/a

Dividends & Yields

HKG:2496 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.47%
Shareholder Yield	-1.47%
Earnings Yield	-6.09%
FCF Yield	-2.43%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:2496 has an Altman Z-Score of -1.44 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.44
Piotroski F-Score	2